Live
Home·Deals·Pharmaceuticals·Servier acquires Day One Biopharma
Servier acquires Day One Biopharma (2026)
SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-5
acquisitionAnnounced · Mar 6, 2026PharmaceuticalsSource · CredibleArticle · Factual
Day One Biopharma
Servier
Day One Biopharma · Servier

Servier acquires Day One Biopharma

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$2.5B
Target
Day One Biopharma
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Servier
Full Acquisition
Status
Pending

Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Brisbane, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier rare oncology portfolio Back to news Servier and Day One Biopharmaceuticals announce acquisition to expand Servier rare oncology portfolio 6 March 2026 Acquisition positions Servier as a leader in pediatric low-grade glioma and expand s its pipeline with programs targeting adult and pediatric cancers with high unmet needs

Deal timeline

Announced
Mar 6, 2026 · servier.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Pharmaceuticals with a reported deal value of $2.5B. Figures and status may change as sources update.

Sources: servier.com · Primary article · FireStrike proprietary index